| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.001 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |